DNA Methylation, Mechanisms of <i>FMR1</i> Inactivation and Therapeutic Perspectives for Fragile X Syndrome
Among the inherited causes of intellectual disability and autism, Fragile X syndrome (FXS) is the most frequent form, for which there is currently no cure. In most FXS patients, the <i>FMR1</i> gene is epigenetically inactivated following the expansion over 200 triplets of a CGG repeat (...
Main Authors: | Veronica Nobile, Cecilia Pucci, Pietro Chiurazzi, Giovanni Neri, Elisabetta Tabolacci |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-02-01
|
Series: | Biomolecules |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-273X/11/2/296 |
Similar Items
-
Transcriptional Reactivation of the FMR1 Gene. A Possible Approach to the Treatment of the Fragile X Syndrome
by: Elisabetta Tabolacci, et al.
Published: (2016-08-01) -
Reversion to Normal of <i>FMR1</i> Expanded Alleles: A Rare Event in Two Independent Fragile X Syndrome Families
by: Elisabetta Tabolacci, et al.
Published: (2020-02-01) -
Reevaluation of FMR1 Hypermethylation Timing in Fragile X Syndrome
by: Hagar Mor-Shaked, et al.
Published: (2018-02-01) -
Pharmacological Reactivation of the Silenced <i>FMR1</i> Gene as a Targeted Therapeutic Approach for Fragile X Syndrome
by: Daman Kumari, et al.
Published: (2019-02-01) -
Small Molecules Targeting H3K9 Methylation Prevent Silencing of Reactivated <i>FMR1</i> Alleles in Fragile X Syndrome Patient Derived Cells
by: Daman Kumari, et al.
Published: (2020-03-01)